Riskpilot← Back to searchSign inGet full accessGLADBAKK LEGESENTER AS
ASActiveOrg 915858473Trondheimsvegen 266-268, 2070 RåholtGeneral medical practice activities · NACE 8621Est. 20154 employees
Revenue 2025
NOK 4,7M
+2% vs 2024
EBITDA margin
3.0%
+259% vs 2024
Equity ratio
46.6%
Financial strength
Net profit 2025
NOK 129K
+234% vs 2024
| Revenue | NOK 4,7M | +2% |
| EBITDA | NOK 139K | +259% |
| Net profit | NOK 129K | +234% |
| Total assets | NOK 423K | +15% |
| Equity | NOK 197K | +189% |
| Employees | 4 | — |
Legal name
GLADBAKK LEGESENTER AS
Org number
915858473
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
8. september 2015
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Legesentervirksomhet med alt som naturlig faller inn under dette, samt eie og delta i andre selskaper.
Address
Trondheimsvegen 266-268, 2070 Råholt
Phone
+4763959490
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 647 | 3 647 | 4 523 | 4 549 | 4 652 |
| Staff expenses | −1 549 | −1 638 | −1 769 | −1 955 | −2 028 |
| EBITDA | 118 | −242 | 257 | 39 | 139 |
| Depreciation & amort. | −51 | −30 | −0 | −0 | −0 |
| EBIT | 66 | −272 | 257 | 39 | 139 |
| Net financials | −0 | 0 | 0 | 0 | 0 |
| Profit before tax | 66 | −272 | 257 | 39 | 139 |
| Tax | −0 | −0 | −0 | −0 | 10 |
| Net profit | 66 | −272 | 257 | 39 | 129 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 843 | 585 | 329 | 368 | 423 |
| Equity | 45 | −227 | 30 | 68 | 197 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 798 | 812 | 299 | 299 | 226 |
| Total debt | 798 | 812 | 299 | 299 | 226 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20212025
Equity ratio
46.6%
This company
38.2%
Market median
+22% vs market
20212025
Return on equity
65.4%
This company
18.4%
Market median
+255% vs market
20212025
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20212025
Asset turnover
10.99×
This company
1.12×
Market median
+881% vs market
20212025
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2018 – 2022 | |
| Chairman | 2018 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GLADBAKK LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Siri Bækkelund Engen | Board of Directors | 0 companies |
| Sameha Aslam | Board of Directors | 0 companies |
| Carl Magnus Jensen | Chairman | 0 companies |
| Eric Tande Håland | Board of Directors | 0 companies |